Infomedtemas de salud
  • Universidad Virtual de Salud
  • Biblioteca Virtual de Salud
Hipertensión • Sitio web dedicado a la hipertensión en Cuba
Inicio Acerca de Recursos de información Docencia Herramientas Contacto
 
Inicio > 2011 > octubre

octubre 2011 Archivos

« sep, 2011 • nov, 2011 »
11/10/2011

Managing kidney disease with blood-pressure control

oct 11th, 2011. En: Propuestas del editor. #

Comentando11Managing kidney disease with blood-pressure control

Por: Elke Wühl and Franz Schaefer.  Nat. Rev. Nephrol. 7, 434–444 (2011).

The progression of chronic kidney disease (CKD) is largely independent of the underlying kidney disorder once renal function has fallen below a critical level. Hypertension is an independent risk factor for disease progression in both adult and pediatric patients with kidney disorders. Increasing evidence from clinical trials indicates that the rate of CKD progression can be lowered by pharmacological interventions. Nephroprotective strategies currently focus on the blockade of the renin–angiotensin system.

Relacionado con: Enfermedad renal.

Prevalence and incidence of hypertension in a population cohort of people aged 65 years or older in Spain

oct 11th, 2011. En: Propuestas del editor. #

Prevalence and incidence of hypertension in a population cohort of people aged 65 years or older in Spain

Por: Gutiérrez-Misis, Aliciaa, Sánchez-Santos, Maria T., Banegas, Jose R., Zunzunegui, Maria V., Castell, Maria V. y Otero, Angela.

To estimate the prevalence and incidence of hypertension in a Spanish cohort of people aged at least 65 years with 13 years’ follow-up. This is the first study to provide age-adjusted and sex-adjusted incidence rates of hypertension in a Mediterranean-based population aged 65 years or older.

Population-based longitudinal study set in the city of Leganes, Spain. The cross-sectional prevalence of hypertension was estimated using data available for the 1993, 1995, 1999, and 2006 cohorts. The incidence density (incident cases of hypertension/person-years) was calculated for 522 individuals without hypertension at baseline. Individuals were classified as hypertensive if they were taking physician-prescribed medication for hypertension or if their blood pressure was equal to or greater than 140/90 mmHg.

Hypertension prevalence increased progressively with time, from 53.5% in 1993 to 86.2% in 2006. In all four waves, women had a higher prevalence of hypertension than men (P < 0.05). The total incidence density of hypertension was 7.6 [95% confidence interval (CI) 6.6–8.7] cases per 100 person-years of follow-up: 9.0 (95% CI 7.2–11.2) in women and 6.9 (95% CI 5.8–8.3) in men. In all age groups, the incidence density was nonsignificantly higher in women than in men (P > 0.05).

Both the incidence and prevalence of hypertension in this population of people aged at least 65 years were high, and the prevalence increased dramatically over time, especially among women.

Fuente
: Journal of Hypertension: October 2011 – Volume 29 – Issue 10 – p: 1863–1870.

Relacionado con: España.

Ambulatory versus conventional methods for monitoring blood pressure during pregnancy

oct 11th, 2011. En: Propuestas del editor. #

0

Ambulatory versus conventional methods for monitoring blood pressure during pregnancy



cochranePor: Bergel Eduardo, Carroli Guillermo, Althabe Fernando

Cochrane Database of Systematic Reviews, Issue 08, 2011 (Status in this issue)

The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. DOI: 10.1002/14651858.CD001231.pub2

This review should be cited as: Bergel Eduardo, Carroli Guillermo, Althabe Fernando. Ambulatory versus conventional methods for monitoring blood pressure during pregnancy. Cochrane Database of Systematic Reviews. In: The Cochrane Library, Issue 08, Art. No. CD001231. DOI: 10.1002/14651858.CD001231.pub2

Abstract


Hypertensive disorders are among the most common medical complications of pregnancy and a leading cause of maternal and perinatal morbidity and mortality world-wide. Blood pressure measurement plays a central role in the screening and management of hypertension during pregnancy. In recent years the validity of conventional (clinic) blood pressure measurement has been questioned and efforts have been made to improve the technique with ambulatory automated devices that provide a large number of measurements over a period of time, usually a 24-hour period.

(ver más)

Relacionado con: Embarazo.

12/10/2011

Síndrome de Piernas Inquietas e hipertensión en mujeres de mediana edad

oct 12th, 2011. En: Propuestas del editor. #

Síndrome de Piernas Inquietas e hipertensión en mujeres de mediana edad

Por: Salma Batool-Anwar, Atul Malhotra, John Forman, John Winkelman, Yanping Li y Xiang Gao.

Una investigación limitada indica una relación entre el síndrome de piernas inquietas y la hipertensión, por lo que, se evaluó la

relación entre el síndrome de piernas inquietas y la hipertensión entre mujeres de mediana edad. Este estudio transversal

con 65 544 mujeres (edad 41-58 años) que participan en el II Nurses ‘Health Study, fueron excluidos los participantes con diabetes mellitus y artritis, debido a que estas condiciones pueden simular el síndrome de piernas inquietas.

El síndrome de piernas inquietas se evaluó mediante un cuestionario auto-administrado sobre la base de los criterios internacionales de Piernas Inquietas Grupo de Estudio, la información sobre el diagnóstico de la hipertensión y los valores de presión arterial se recogieron a través de cuestionarios. Modelos de regresión logística multivariable se utilizó para analizar la relación entre el síndrome de piernas inquietas y la hipertensión, con ajuste por edad, raza, índice de masa corporal, actividad física, el estado menopáusico, el tabaquismo, el uso de analgésicos, y la ingesta de alcohol, cafeína, ácido fólico, y de hierro.
En comparación con las mujeres sin síntomas de piernas inquietas, las probabilidades de varios ajustada de hipertensión fueron 1,20 veces (IC 95%: 1,10-1,30, p <0,0001) mayor entre las mujeres con síntomas de piernas inquietas.

(Fuente: Hypertension October 2011, Volume 58, Issue 4.)

Relacionado con: Sexo femenino.

Asociación de ATP1B1, RGS5 y polimorfismos SELE con la hipertensión en los afro-americanos

oct 12th, 2011. En: Propuestas del editor. #

2-riesgo-cardiovascularAsociación de ATP1B1, RGS5 y polimorfismos SELE con la hipertensión en los afro-americanos [en inglés]

Por: Faruque, Mezbah U.; Chen, Guanjie; Doumatey, Ayo; Huang, Hanxia; Zhou, Jie; Dunston, Georgia M.; Rotimi, Charles N.; Adeyemo yAdebowale A. Journal of Hypertension: October 2011 – Volume 29 – Issue 10 – p 1906–1912.

Aunque un número creciente de pacientes con hipertensión asociada a variantes genéticas se informa que la replicación de estos resultados en estudios independientes ha sido un desafío. Varios genes en una región en el cromosoma humano vinculación 1q se ha informado que se asocian con la hipertensión. Examinamos en este estudio los polimorfismos en tres de estos genes (ATP1B1, RGS5 y SELE) en relación con la hipertensión y la presión arterial en una cohorte de los afro-americanos.

Relacionado con: Afrodescendientes, Genética.

Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials

oct 12th, 2011. En: Propuestas del editor. #

Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials

cochrane1Por: WheltonP K, HeJ, CutlerJ A, BrancatiF L, AppelL J, FollmannD and KlagM J, . Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials. JAMA 1997;277(20) :1624-1632.

Authors’ objectives

To assess the effects of supplementation with oral potassium on blood-pressure (BP) in humans.

Searching

MEDLINE was searched using the terms ‘blood pressure’, ‘dietary potassium’, ‘potassium’ and ‘potassium chloride’. Bibliographies of original articles and reviews, and the authors’ own reference files were also examined. Only English-language articles published before 1995 were considered.

Study selection: study designs

Randomised controlled trials (RCTs) of either parallel or crossover design were included. The duration of the studies varied from 4 days to 3 years.

Study selection: specific interventions

Potassium supplementation administered as a pill (in the form of potassium chloride, potassium citrate and bicarbonate) or as part of the diet. Dosage of potassium prescribed in the intervention arm was at least 60 mmol/day in all but 2 trials, and at least 100 mmol/day in 10 trials (median, 75 mmol/day). The intervention arm was compared to a control group of either placebo, lower dose of potassium, or no supplementation. Antihypertensive medications were administered concurrently in 4 of the trials.

Study selection: participants

Both hypertensive and normotensive participants (aged 19 years) were included in the review.

Study selection: outcomes

The net change from pre-treatment to end of follow-up in urinary excretion of sodium and potassium, body weight, and BP (systolic and diastolic) for treatment and control conditions. The mean 24-hour urinary sodium excretion during follow-up, recorded at the trial’s end.

Study selection: how were decisions on the relevance of primary studies made?

The primary studies were assessed independently for relevance by two of the review’s authors. Areas of disagreement or uncertainty were adjudicated by other authors.

Validity assessment

No formal validity assessment was carried out, although study design details were recorded during the data extraction phase; these included whether the trial was of parallel, crossover or open design, single-blind or double-blind. Details of the study design were recorded independently by two of the authors who were blinded to each other’s coding. This process was carried out during the data extraction phase.

Results of the review

Thirty-three RCTs (1,560 hypertensive and 1,005 normotensive participants) were included: 3 of crossover open design, 2 crossover single-blind, 16 crossover double-blind, 4 parallel open, 1 parallel single, and 7 parallel double-blind.

Due to significant variation in effect size across the 33 trials, only results from the random-effects model are presented.

CRD database number: DARE-11997008171

Index terms

Subject index terms
Subject indexing assigned by NLM: Medical Subject Headings (MeSH): Administration, Oral; Blood Pressure[drug effects]; Food, Fortified; Hypertension[prevention & control]; Potassium[administration & dosage]; Potassium[pharmacology]; Potassium[urine]; Randomized Controlled Trials as Topic; Sodium[urine]; Statistics as Topic

A multimodal blood pressure control intervention in 3 healthcare systems.

oct 12th, 2011. En: Propuestas del editor. #

A multimodal blood pressure control intervention in 3 healthcare systems.

pub-medPor: Magid DJ, Ho PM, Olson KL, Brand DW, Welch LK, Snow KE, Lambert-Kerzner AC, Plomondon ME y Havranek EP.
Source: Am J Manag Care. 2011 Apr;17(4):e96-103.

Institute for Health Research, Kaiser Permanente Colorado, Denver, USA. david.j.magid@kp.org

OBJECTIVE:

To determine if a multimodal intervention composed of patient education, home blood pressure (BP) monitoring, BP measurement reporting to an interactive voice response (IVR) phone system, and clinical pharmacist follow-up improves BP control compared with usual care.
STUDY DESIGN:

Prospective study with patient enrollment, medication consultation and adjustment, remote BP monitoring, and follow-up at 6 months.

METHODS:

This randomized controlled trial was conducted at 3 healthcare systems in Denver, Colorado, including a large health maintenance organization, a Veterans Affairs medical center, and a county hospital. At each site, patients with uncontrolled BP were randomized to the multimodal intervention vs usual care for 6 months, with the primary end point of BP reduction.

RESULTS:

Of 338 patients randomized, 283 (84%) completed the study, including 138 intervention patients and 145 usual care patients. Baseline BP was higher in the intervention group vs the usual care group (150.5/89.4 vs 143.8/85.3 mm Hg). At 6 months, BPs were similar in the intervention group vs the usual care group (137.4 vs 136.7 mm Hg, P = .85 for systolic; 82.9 vs 81.1 mm Hg, P = .14 for diastolic). However, BP reductions were greater in the intervention group vs the usual care group (−13.1 vs −7.1 mm Hg, P = .006 for systolic; −6.5 vs −4.2 mm Hg, P = .07 for diastolic). Adherence to medications was similar between the 2 groups, but intervention patients had a greater increase in medication regimen intensity.

CONCLUSIONS:

A multimodal intervention of patient education, home BP monitoring, BP measurement reporting to an IVR system, and clinical pharmacist follow-up achieved greater reductions in BP compared with usual care.
PMID: 21774100.

1 2 3

Información básica

  • ¿Qué es la hipertensión arterial?
  • Causas
  • Síntomas
  • Diagnóstico
  • Tratamiento
  • Medicamentos
  • Prevalencia en Cuba

Nuestra Red de Portales

  • Especialidades: Cirugía cardiovascular
  • Instituto de Cardiología y Cirugía Cardiovascular
  • Tema: Anestesiología cardiovascular

Sitios de la red relacionados

  • Especialidades: Medicina Interna
  • Especialidades: Nefrología

Personalidades

  • Profesor Dr. Alfredo Dueñas Herrera
  • Profesor DSc. David Orlando García Barreto
  • Profesor Dr. Ignacio R. Macías Castro
  • Ver más...

Campaña promocional

Día Mundial de la Hipertensión

Sin título

Comentarios recientes

  • hipertension en Hipertensión Arterial. Guía de actuación para la atención primaria de salud
  • yacuna en Hipertensión Arterial. Guía de actuación para la atención primaria de salud
  • yenis marla labori prado en Curso nacional “Atención integral al paciente hipertenso”, del 16 al 20 de mayo del 2022

Libro de Visitas

Su opinión es importante

escribir

rss rojo mapa_de_sitio rojo contacto rojo lupa buscar

Seleccione por temáticas

A mano

guia hipertension 2017

noticias al dia hipertensión

Acceda desde aquí a las noticias sobre hipertensión arterial

RSS Science Daily News

  • How measuring blood pressure in both arms can help reduce cardiovascular risk and hypertension 03/08/2022
  • Most high blood pressure in children and teenagers is linked with unhealthy lifestyle 28/07/2022
  • Cocoa shown to reduce blood pressure and arterial stiffness in real-life study 26/07/2022
  • Adolescent arterial stiffness -- a novel risk factor for hypertension and insulin resistance 25/07/2022
  • Women urged to eat potassium-rich foods to improve their heart health 22/07/2022
  • Hypertension elevates risk for more severe COVID-19 illness 20/07/2022

Espacios de interacción

lista de discusión

Sitios recomendados

  • Organizaciones y sociedades
  • Congresos (histórico)
  • Infoenlaces

Estadísticas de visitas

Map

Vea las estadísticas en tiempo real

Historial del sitio

Fecha de actualizacion

Actualizado: 11/08/2022

Publicado oficialmente el
30 de noviembre de 2003

En WordPress desde el año 2016

MSc. Roberto Rafael Pérez Moreno: Editor principal | Esp. II Grado Medicina Interna. Farmacoepidemiologo. Profesor Auxiliar : Hospital Comandante Manuel Fajardo | Calle D y Zapata, Plaza, La Habana, 10400, Cuba  | Teléfs: 7838 2453, Horario de atención: De 8:00 a.m. a 5:00 p.m., de lunes a sábado
Políticas del Portal. Los contenidos que se encuentran en Infomed están dirigidos fundamentalmente a profesionales de la salud. La información que suministramos no debe ser utilizada, bajo ninguna circunstancia, como base para realizar diagnósticos médicos, procedimientos clínicos, quirúrgicos o análisis de laboratorio, ni para la prescripción de tratamientos o medicamentos, sin previa orientación médica.
© 1999-2022 Infomed - Centro Nacional de Información de Ciencias Médicas
Made with an easy to customize WordPress theme • Boxed, Red skin by Denis de Bernardy